当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析 - 现金流量表

泰格医药

(300347)

  

流通市值:301.80亿  总市值:455.84亿
流通股本:5.78亿   总股本:8.72亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金5,043,275,819.723,310,082,306.611,525,588,216.356,623,183,534
收到的税费返还13,496,958.976,355,082.493,132,366.7235,039,969.03
收到其他与经营活动有关的现金246,618,696.13182,154,184.51101,622,867.35286,120,550.96
经营活动现金流入的平衡项目0000
经营活动现金流入小计5,303,391,474.823,498,591,573.611,630,343,450.426,944,344,053.99
购买商品、接受劳务支付的现金1,585,303,250.11,072,712,094.43560,501,200.692,250,284,877.47
支付给职工以及为职工支付的现金2,239,495,755.411,530,130,605.35788,727,243.262,455,570,893.73
支付的各项税费481,854,173.19338,405,234.03156,458,892.84629,886,900.39
支付其他与经营活动有关的现金324,093,814.56182,302,384.4696,147,894.23251,100,489.99
经营活动现金流出的平衡项目0000
经营活动现金流出小计4,630,746,993.263,123,550,318.271,601,835,231.025,586,843,161.58
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额672,644,481.56375,041,255.3428,508,219.41,357,500,892.41
二、投资活动产生的现金流量:
收回投资收到的现金655,787,863.24349,639,774.18226,292,373.29423,931,469.73
取得投资收益收到的现金20,904,699.511,194,612.0510,327,547.316,353,001.74
处置固定资产、无形资产和其他长期资产收回的现金净额4,796,524.84,761,803.696,806.672,019,261.98
收到的其他与投资活动有关的现金49,218,222.0339,388,834.6316,564,887.31148,236,713.76
投资活动现金流入的平衡项目0000
投资活动现金流入小计730,707,309.57404,985,024.55253,191,614.58580,540,447.21
购建固定资产、无形资产和其他长期资产支付的现金212,954,200.9156,979,499.0383,626,244.32448,603,106.3
投资支付的现金1,735,920,304.15956,088,659.08716,665,838.362,203,324,983.43
取得子公司及其他营业单位支付的现金344,200,483.9--663,086,105.75
支付其他与投资活动有关的现金30,137,169.18476,786.42412,353.4754,892,114.51
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,323,212,158.131,113,544,944.53800,704,436.153,369,906,309.99
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,592,504,848.56-708,559,919.98-547,512,821.57-2,789,365,862.78
三、筹资活动产生的现金流量:
吸收投资收到的现金246,021,485.15243,589,15682,420,000315,400,000
其中:子公司吸收少数股东投资收到的现金242,460,000240,060,000--
取得借款收到的现金2,807,145,394.971,455,850,834.02460,400,908.023,441,413,597.07
收到其他与筹资活动有关的现金4,518,909.423,890,982.741,040,681.0223,722,433.07
筹资活动现金流入平衡项目0000
筹资活动现金流入小计3,057,685,789.541,703,330,972.76543,861,589.043,780,536,030.14
偿还债务支付的现金1,845,119,104.61896,841,185.47170,156,793.881,834,697,260.1
分配股利、利润或偿付利息支付的现金570,880,007.0966,323,828.5842,139,775.41491,995,891.33
其中:子公司支付给少数股东的股利、利润15,502,719.3614,497,540.33--
支付其他与筹资活动有关的现金166,825,436.32119,095,755.7929,403,777.52644,588,966.24
筹资活动现金流出平衡项目0000
筹资活动现金流出小计2,582,824,548.021,082,260,769.84241,700,346.812,971,282,117.67
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额474,861,241.52621,070,202.92302,161,242.23809,253,912.47
四、汇率变动对现金及现金等价物的影响22,207,055.1425,879,265.82-11,111,360.8226,934,264.86
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-422,792,070.34313,430,804.1-227,954,720.76-595,676,793.04
加:期初现金及现金等价物余额7,782,740,887.027,782,740,887.027,782,740,886.948,378,417,680.06
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额7,359,948,816.688,096,171,691.127,554,786,166.187,782,740,887.02
补充资料:
净利润-1,408,089,992.74-2,271,725,425.73
资产减值准备-29,777,475.56-25,020,600.35
固定资产和投资性房地产折旧-53,116,443.75-94,086,532.76
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-53,116,443.75-94,086,532.76
无形资产摊销-34,072,552-64,605,785.82
长期待摊费用摊销-15,402,998.59-20,099,988.78
处置固定资产、无形资产和其他长期资产的损失-5,900.81-86,629.45
公允价值变动损失--529,757,595.42--535,857,333.93
财务费用-32,279,928.72-63,047,384.18
投资损失--98,902,116.93--102,750,723.9
递延所得税--3,183,427.17--7,564,299.94
其中:递延所得税资产减少--20,179,241.9--20,417,652.85
递延所得税负债增加-16,995,814.73-12,853,352.91
存货的减少--4,330,245.15--16,109,361.37
经营性应收项目的减少--600,242,824.89--869,249,847.78
经营性应付项目的增加--88,072,263.88-193,782,148.71
其他-67,277,980.65-50,525,000.04
现金的期末余额-8,096,171,691.12-7,782,740,887.02
减:现金的期初余额-7,782,740,887.02-8,378,417,680.06
公告日期2023-10-282023-08-262023-04-262023-03-29
审计意见(境内)标准无保留意见
TOP↑